SVS branding campaign wins communications award

The Society for Vascular Surgery (SVS) branding campaign has received a “Profiles of Excellence Award” from the American Association of Medical Society Executives for outstanding achievement by medical societies. The SVS won its award in the communications category, for “initiatives…
‘Do we need to do a better job of making devices that fit female anatomy?’

It was a burning question posed from the conference floor, and it led to some approving social media nods in its aftermath: Does the tone of conversation around the vascular anatomy of females need to morph into a discussion about…
Five-year ACST-2 results: Carotid artery surgery and stenting have similar long-term effects on stroke

Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis. That is the finding of late-breaking ACST-2 data presented in a Hot Line session at the European Society of Cardiology’s 2021…
VAM discussion on latest paclitaxel meta-analysis yields mix of caution, skepticism

A Vascular Annual Meeting (VAM) sponsored session on paclitaxel safety drew a mix of skeptical and cautious responses to the latest meta-analysis from interventional radiologist Konstantinos Katsanos, MD, that reported a heightened risk of major amputation after use of paclitaxel-coated balloons…
Caring for the veteran, training the surgeon: The role of the VA in vascular surgery training

In May 1945, President Harry Truman appointed Gen. Omar Bradley to lead what is now the United States Department of Veteran Affairs, with Paul Howley, MD, as chief medical director and orthopedic surgeon Paul Magnuson, MD, as his aide.1,2 Colloquially,…
TCAR has ‘statistically equivalent’ stroke and death outcomes to CEA, new study finds

Silk Road Medical has announced positive results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularization (TCAR) for atherosclerotic carotid disease. The data were presented at the Society for Vascular Surgery (SVS) 2021 Vascular Annual Meeting…
Won’t be in San Diego? Register for livestreamed/on-demand sessions

The Society for Vascular Surgery (SVS) 2021 Vascular Annual Meeting (VAM) in San Diego (Aug. 18–21) starts in mere days. For those who face travel or other restrictions and cannot attend in person, the SVS has a technical alternative: livestreaming.…
‘VSITE predicts Qualifying Exam success’

The Vascular Surgery In-Training Examination (VSITE) is “highly predictive” of a Vascular Qualifying Examination pass for examinees following both the integrated vascular surgery (0+5) and vascular fellowship (5+2) training paradigms, Vincent L. Rowe, MD, professor of surgery at the University…
Just 16% of US centers in VQI offer SVS guideline-compliant open repair for AAA, new study finds

There is a stark downward trend in the number of U.S. centers in the Vascular Quality Initiative (VQI) that meet the Society for Vascular Surgery (SVS) clinical practice guidelines for open repair of abdominal aortic aneurysm (AAA), new research to…
Study shows increase in risk of renal failure following lytic therapy for acute DVT

A large, single-centre retrospective study has revealed the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower-extremity deep vein thrombosis (DVT) is as high as 22%. This findings add “significant knowledge” to understanding the risks of lytic…

